Přejít k obsahu
Global sound
Dr. Chapa’s OBGYN Clinical Pearls

Dr. Chapa’s OBGYN Clinical Pearls

Myfembree as BC? ASRM Data

· 18 min

Poznámky k epizodě

Back in 2021, we discussed the FDA approval of a combination GNRH antagonist (relagolix) with estradiol and norethindrone. This was originally approved to treat uterine fibroid related heavy menstrual bleeding. It is also now approved for endometriosis care. In theory, this should also be an effective contraceptive agent. However, the FDA label strictly cautions against its use for birth control. In this episode, we will discuss data from the recent ASRM 2026 annual conference that looked at this medication's ability to possibly function as hormonal contraception. But there is a catch. Listen in for details.
1. https://www.medscape.com/viewarticle/fibroid-drug-relugolix-may-act-contraceptive-2026a10015db
2. Myfembreehcp.com

Web: podcasters.spotify.com

Živě, poslední hodina: 6 643 skladeb na 2 313 stanicích v 108 zemích

Objevte svět prostřednictvím rádia

Další způsoby objevování (7)

Slyšeli jste něco pěkného? Uložte si to, nebo to otevřete rovnou ve Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Cyberspazio RadioPokračovat v poslechu